No Data
No Data
Express News | Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aligos Therapeutics to Present at Investor Conferences in December
Express News | Adage Capital Management, L.p. Reports 7.12% Passive Stake in Aligos Therapeutics as of Sept 30 - SEC Filing
Express News | Aligos Therapeutics Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 60%
Express News | Aligos Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Revenue Results. HC Wainwright & Co. Reiterated a Buy Rating on the Stock